Farmaceutici Caber

Farmaceutici Caber was a prominent Italian pharmaceutical firm based in Pisa, specializing in the development and commercialization of therapeutic solutions for the domestic market. The company maintained a diverse portfolio with a particular emphasis on rheumatology, respiratory medicine, and cardiovascular health. It was well-known for its range of corticosteroid treatments and other essential medicines. Following its acquisition by the Sigma-Tau Group, the company was eventually absorbed into Alfasigma after the 2015 merger between Sigma-Tau and Alfa Wassermann. Today, Farmaceutici Caber exists as a legacy brand within the Alfasigma organization, which continues to manufacture and distribute its core products.